Status: awaiting_review. Rule: atlas-profile-2.0.
2 linked publications; not a count of independent studies.
Missing appraisal does not mean no evidence exists. Inspect the full profile and source relationships in the interactive Atlas.
Historical grade: WEAK (retained from 22 September 2026; not a completed profile 2.0 assessment).
Chemical-shift signal drop and ADC thresholds separate benign from malignant marrow with good performance
Thresholds vary across sites/vendors, acute benign fractures overlap with malignant, and no universal ADC cutoff holds
Determines staging and biopsy; misread drives unnecessary biopsy or missed metastasis.
This is an educational research resource from Resonant Labs, not clinical advice. Atlas assessments are heuristic, not probabilities or formal GRADE ratings. Findings are summarized from the literature and may change as the field evolves.